There is a significantly increased risk of death due to gastrointestinal diseases (primarily hepatic disease) in patients with rosacea, a recent study found. Researchers conducted a population-based cohort study (n=35,958) that included 5,993 patients with rosacea and 29,965 age- and sex-matched individuals. They found:

• During the maximum 15 years of follow-up, 664 (11.1%) patients with rosacea and 3,121 (10.4%) patients in the reference population died.
• The risk of all-cause mortality was similar in patients with rosacea and the reference population.
• Analyses of cause-specific mortality revealed a significantly increased risk of death due to gastrointestinal diseases in patients with rosacea, primarily related to hepatic disease.
• No increased risk of death due to other major disease categories (eg, cancer, cardiovascular, neurological, or infectious diseases) was observed.